from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1695/ppnK

LFCtreatmentdescriptionclass of inhibitor

-1.127

Amikacinug/mL Amikacintranslation

-1.293

Cap5-10ug/mL Capreomycintranslation

-2.530

Rox10-50 ug/mL Roxithromycintranslation

0.253

SM2-5 ug/mL Streptomycintranslation

0.745

Tet5-10 ug/mL Tetracyclinetranslation

1.141

Rif0.2-5ug/mL Rifampicintranscription

0.426

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.628

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.508

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.545

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.274

Clofazimine10-13 ug/mL Clofaziminerespiration

0.536

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.299

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.294

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.324

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.054

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.633

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.596

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.373

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.716

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.223

KCN5-20 ug/mL Potassium cyaniderespiration

-0.138

NaN30.2-2 mM Sodium aziderespiration

-0.349

Nigericin50 uM Nigericinrespiration

1.321

TRC10-150 ug/mL Triclosanrespiration

-0.964

TRZ10-25 ug/mL Thioridazinerespiration

-2.267

Valinomycin0.5-10 uM Valinomycinrespiration

-0.173

ZnSO42 mM ZnSO4respiration

0.060

menadione6-10 ug/mL Menadionerespiration

-0.195

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.028

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.406

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.484

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.349

NRP_1Non-replicating persistence stage 1dosRassociated

0.155

Amp0.2mg/mL AmpicillincellWall

0.423

Cephalexin20-100 ug/mL CephalexincellWall

-0.393

Cerulenin0.32-5 ug/mL CerulenincellWall

0.047

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.264

EMB10-20 ug/mL EthambutolcellWall

0.535

Eta12-40 ug/mL EthionamidecellWall

1.058

INH0.2-0.4 ug/mL IsoniazidcellWall

0.356

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.574

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.260

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.057

BZA0.12 mg/mL BenzamidearomaticAmides

0.062

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.004

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.048

H2O24 mM hydrogen peroxideDNAdamaging

-0.146

Levo10 ug/mL LevofloxacinDNAdamaging

-0.143

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.224

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.696

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.560

UVUV-irradiationDNAdamaging

-1.690

ARP41-4 ug/mL Antitubercular compound ARP4?

0.040

Antimycin12.5-50 ug/mL Antimycin A?

-0.113

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.210

PA_110-50 ug/mL Antitubercular compound PA-1?

0.740

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.539

PA8240.2-2 ug/mL PA-824?

-0.227

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.410

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.168

Verapamil50 uM Verapamil?

0.043

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.021

methoxatin10-20 ug/mL Methoxatin?